Decreased Vascular Permeability [PE] - N0000010252

Pharmacologic Code	N0000010252
Pharmacologic Name	Decreased Vascular Permeability
Pharmacologic Uses	human C1 esterase inhibitor
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Decreased Vascular Permeability [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	42227-081	Cinryze	Non-Proprietary Name: Human C1-esterase Inhibitor	Injection, Powder, Lyophilized, For Solution	Intravenous	Takeda Pharmaceuticals America, Inc.	ACTIVE